Healthcare Molecular Diagnostics Biotechnology Precision Medicine
Founded
Salt Lake City, Utah, United States (1991)
Headquarters
Salt Lake City, Utah
Key people
Paul J. Diaz, President and CEO Mark Skolnick, Co-Founder Peter Meldrum, Co-Founder Kevin Kimberlin, Co-Founder Jerry Lanchbury, CSO Walter Gilbert, Director and Vice Chair
Revenue
$690.6 Million(2021)[1]
Number of employees
2,600[2]
Website
www.myriad.com
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to a particular drug therapy (precision medicine), assess a patient's risk of disease progression and disease recurrence (precision medicine), and measure disease activity.
^"Myriad Genetics Reports Fourth Quarter 2021 Results, Provides Updates on Product Performance and Growth Initiatives". 24 February 2021.
^"Myriad's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile".
MyriadGenetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number...
Pathology v. MyriadGenetics lawsuit mentioned below. The patents expire, starting in 2014. Association for Molecular Pathology v. MyriadGenetics was a 2013...
patents owned or controlled by MyriadGenetics. Myriad's business model of offering the diagnostic test exclusively led from Myriad being a startup in 1994 to...
patents owned or controlled by MyriadGenetics. Myriad's business model of exclusively offering the diagnostic test led to Myriad growing from being a startup...
Pathology v. MyriadGenetics lawsuit. The patents begin to expire in 2014. Peter Meldrum, CEO of MyriadGenetics, has acknowledged that Myriad has "other...
parents to screen for Mendelian diseases. Counsyl was acquired by MyriadGenetics for $375 million in 2018. In 2013, Srinivasan joined the venture capital...
John Nicholas ruled in the Federal Court of Australia in favour of a MyriadGenetics patent on the BRCA1 gene. This was a landmark ruling, affirming the...
US Supreme Court decision in Association for Molecular Pathology v. MyriadGenetics, Inc. As a compromise, the Court declared, that exons-only cDNA is...
for genomics and proteomics predictive cancer test products made by MyriadGenetics, Inc. In May 2002, Labcorp announced the acquisition of all outstanding...
2013 U.S. Supreme Court ruling invalidated BRCA gene patents held by MyriadGenetics. As the daughter of actor Jon Voight, Jolie appeared in the media from...
Prometheus Laboratories, Inc.(2012), Association for Molecular Pathology v. MyriadGenetics, Inc. (2013) and Alice Corp. v. CLS Bank International (2014) limiting...
mitochondrial disease.[citation needed] GeneDx settled a patent dispute with MyriadGenetics in February 2015 after GeneDx launched a BRCA mutation breast cancer...
losing party – a startup MyriadGenetics, Inc. – at the US Supreme Court in Association for Molecular Pathology v. MyriadGenetics, Inc. Marvin Bower, McKinsey...
patents on DNA sequences were allowable. In 2010 in the US, AMP sued MyriadGenetics to challenge the latter's patents regarding two genes, BRCA1, BRCA2...
several years, research and trials for the drug were conducted by MyriadGenetics, to investigate its potential as a treatment for Alzheimer's disease;...
Utah, National Institute of Environmental Health Sciences (NIEHS) and MyriadGenetics. The Western Hemisphere is declared free of polio. November 9 – Darmstadtium...
trials. MyriadGenetics announced on January 21, 2009 the acquisition of all rights to bevirimat for $7M USD. On June 8, 2010 MyriadGenetics announced...
against Salt Lake City-based MyriadGenetics. MyriadGenetics held a complete monopoly on BRCA testing in the United States as Myriad had held the patents on...
be (Diamond v. Chakrabarty, Association for Molecular Pathology v. MyriadGenetics, Inc.), provided that they are different in a useful manner from their...
Private Cloud environments. 3M Allianz Everly Health Janus Henderson MyriadGenetics Prisma Health ServPro Made in New York List, Made in New York, Retrieved...
Union Sandy Banking 1934 Mountain West Energy Orem Petroleum 2005 MyriadGenetics Salt Lake City Biotechnology 1991 Nature's Sunshine Products Lehi Dietary...
family members. Tests for PALB2 have been developed by Ambry Genetics and MyriadGenetics that are now available. Prophylactic mastectomy should be considered...
applications of sequencing, such as gene testing, after the discovery by MyriadGenetics of the BRCA1 breast cancer gene mutation. Sequence data in Genbank...
diseases. It was founded in 1999 as a spin-off from MyriadGenetics and was originally known as Myriad Pharmaceuticals. Richard B. Brewer was its CEO from...
the work was finished. For example, a number of companies, such as MyriadGenetics, started offering easy ways to administer genetic tests that can show...
Global Information
$690.6 Million(2021)[1]